Xenon Pharmaceuticals Inc.
XENE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001582313
In the last 90 days, Xenon Pharmaceuticals Inc. insiders filed 2 open-market purchases and 2 sales; 315 institutions reported holding it in 13F filings for Q2 2026, worth $6.10B in total; Duquesne Family Office is the only superinvestor holding it.
Q2 2024 vs. Q1 2024
How the institutions holding Xenon Pharmaceuticals Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 220 | 1 | 213 | −6 |
| Shares | 73.5M | 85.3K | 74.2M | +766.8K (+1.0%) |
| Value | $3.16B | $3.67M | $2.89B | −$268.1M (−8.5%) |
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Xenon Pharmaceuticals Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Logos Global Management LP | 375,000 | $14.6M | 1.68% |
| Thrivent Financial for Lutherans | 43,093 | $1.68M | 0.00% |
| Skandinaviska Enskilda Banken AB (publ) | 40,376 | $1.57M | 0.01% |
| Rhenman & Partners Asset Management AB | 35,000 | $1.36M | 0.13% |
| Nebula Research & Development LLC | 30,196 | $1.18M | 0.19% |
| CenterBook Partners LP | 29,153 | $1.14M | 0.07% |
| Campbell & CO Investment Adviser LLC | 24,060 | $938.1K | 0.08% |
| XTX Topco Ltd | 11,910 | $464.4K | 0.04% |
| PEAK6 Investments LLC | 8,000 | $311.9K | 0.01% |
| Fox Run Management, L.L.C. | 6,687 | $260.7K | 0.05% |
| ADAR1 Capital Management, LLC | 4,700 | $183.3K | 0.04% |
| Mirae Asset Global Investments Co., Ltd. | 2,253 | $84.3K | 0.00% |
| KBC Group NV | 1,962 | $76.0K | 0.00% |
| Point72 (DIFC) Ltd | 317 | $12.3K | 0.00% |
| National Bank of Canada | 235 | $8.83K | 0.00% |
| Clearstead Advisors, LLC | 218 | $8.50K | 0.00% |
| Ashton Thomas Private Wealth, LLC | 135 | $5.26K | 0.00% |
| Massmutual Trust Co FSB | 40 | $1.56K | 0.00% |
| Group One Trading, L.P. | 4 | $156 | 0.00% |
| SRS Capital Advisors, Inc. | 3 | $117 | 0.00% |
| CWM, LLC | 7 | $0 | 0.00% |
Sold out (27)
Institutions that held Xenon Pharmaceuticals Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
Not filed for Q2 2024 yet (1)
Institutions that held Xenon Pharmaceuticals Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Credit Suisse AG | 85,339 | $3.67M |